Exenatide vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Exenatide

Exenatide was the first GLP-1 receptor agonist approved in the US, derived from a compound found in Gila monster saliva. Available as Byetta (twice daily) and Bydureon (once weekly extended-release).

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

Aspect	Exenatide	Ipamorelin
Dose Range	5 mcg–10 mcg	100 mcg–300 mcg
Frequency	2x daily	2x daily
Cycle Length	8–24 weeks	8–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	Synthetic version of exendin-4, which activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and promote satiety.	Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical Dosage	Byetta: 5mcg twice daily for 1 month, then 10mcg twice daily. Bydureon: 2mg subcutaneously once weekly.	Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
Administration	Byetta: Inject within 60 minutes before morning and evening meals. Bydureon: Any time of day, with or without meals. Do not mix with insulin in same syringe.	Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side Effects	Nausea (especially initially), vomiting, diarrhea, dizziness, headache, and injection site reactions (particularly with Bydureon).	Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For	Fat Loss	Muscle Growth Fat Loss Recovery & Healing Sleep Quality